Macronutrient intake and physical activity levels in individuals with and without metabolic syndrome: An observational study in an urban population.
Basal Metabolic Rate
Nutritional Assessment
Physical Activity
Journal
ARYA atherosclerosis
ISSN: 1735-3955
Titre abrégé: ARYA Atheroscler
Pays: Iran
ID NLM: 101487337
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
28
8
2019
Statut:
ppublish
Résumé
We aimed to compare dietary macronutrient intake and physical activity level (PAL) between community-based samples of Iranian adults with metabolic syndrome (MetS+) and without metabolic syndrome (MetS-). This cross-sectional study was conducted among 3800 men and women aged 35-65 years. The International Diabetes Federation (IDF) criteria were used to define MetS. A 24-hour recall was used to evaluate dietary intake. The James and Schofield human energy requirements equations were used to calculate PAL and questions were categorized into time spent on activities during work (including housework), during non-work time, and in bed. The mean ± standard deviation (SD)age of the MetS+ and MetS- subjects was, respectively, 48.8 ± 7.8 years (521 men and 1178 women) and 47.6 ± 7.5 years (714 men and 1222 women) (P = 0.930). The mean energy intake was higher in the MetS+ men compared with MetS- men (1977.4 ± 26.6 vs. 1812.7 ± 21.7 Kcal; P < 0.001). Crude and energy-adjusted intake from total fat was lower in MetS+ women compared with MetS- women (both P < 0.010). PALs were lower in MetS+ compared with MetS- participants (P < 0.001). After adjusting for confounders, no significant association was observed between the intake of individual macronutrients and MetS. In contrast, PAL was inversely associated with the incidence of MetS [OR = 0.34 (95% CI: 0.17-0.57); P < 0.001]. In the current study, there was an inverse relationship between PAL and the risk of MetS, but no association between individual dietary macronutrients intake and the incidence of MetS.
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to compare dietary macronutrient intake and physical activity level (PAL) between community-based samples of Iranian adults with metabolic syndrome (MetS+) and without metabolic syndrome (MetS-).
METHODS
METHODS
This cross-sectional study was conducted among 3800 men and women aged 35-65 years. The International Diabetes Federation (IDF) criteria were used to define MetS. A 24-hour recall was used to evaluate dietary intake. The James and Schofield human energy requirements equations were used to calculate PAL and questions were categorized into time spent on activities during work (including housework), during non-work time, and in bed.
RESULTS
RESULTS
The mean ± standard deviation (SD)age of the MetS+ and MetS- subjects was, respectively, 48.8 ± 7.8 years (521 men and 1178 women) and 47.6 ± 7.5 years (714 men and 1222 women) (P = 0.930). The mean energy intake was higher in the MetS+ men compared with MetS- men (1977.4 ± 26.6 vs. 1812.7 ± 21.7 Kcal; P < 0.001). Crude and energy-adjusted intake from total fat was lower in MetS+ women compared with MetS- women (both P < 0.010). PALs were lower in MetS+ compared with MetS- participants (P < 0.001). After adjusting for confounders, no significant association was observed between the intake of individual macronutrients and MetS. In contrast, PAL was inversely associated with the incidence of MetS [OR = 0.34 (95% CI: 0.17-0.57); P < 0.001].
CONCLUSION
CONCLUSIONS
In the current study, there was an inverse relationship between PAL and the risk of MetS, but no association between individual dietary macronutrients intake and the incidence of MetS.
Identifiants
pubmed: 31452662
doi: 10.22122/arya.v15i3.1303
pii: ARYA-15-136
pmc: PMC6698086
doi:
Types de publication
Journal Article
Langues
eng
Pagination
136-145Références
JAMA. 1999 Oct 27;282(16):1539-46
pubmed: 10546693
Int J Obes Relat Metab Disord. 2001 Jan;25(1):45-53
pubmed: 11244457
Physiol Behav. 2003 Nov;80(2-3):253-8
pubmed: 14637223
Neurosci Biobehav Rev. 1992 Winter;16(4):585-96
pubmed: 1480353
Diabetes. 2005 Jan;54(1):158-65
pubmed: 15616024
Ethn Dis. 2005 Spring;15(2):213-20
pubmed: 15825967
Diabetes Care. 2005 Jul;28(7):1769-78
pubmed: 15983333
Diabetes Care. 2005 Jul;28(7):1779-85
pubmed: 15983334
J Nutr. 2005 Aug;135(8):1953-9
pubmed: 16046722
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Nutr Metab (Lond). 2005 Nov 16;2:31
pubmed: 16288655
Am J Clin Nutr. 2006 Dec;84(6):1549; author reply 1550
pubmed: 17158442
Nihon Rinsho. 2006 Dec 28;64 Suppl 9:530-5
pubmed: 17458276
Appl Physiol Nutr Metab. 2007 Jun;32(3):535-6
pubmed: 17510693
Diabetes. 2007 Nov;56(11):2655-67
pubmed: 17827399
J Am Diet Assoc. 2007 Oct;107(10):1755-67
pubmed: 17904936
Arq Bras Endocrinol Metabol. 2007 Dec;51(9):1425-33
pubmed: 18209884
Br J Nutr. 2008 Sep;100(3):576-84
pubmed: 18328117
Ciba Found Symp. 1991;156:3-10; discussion 10-6
pubmed: 1855414
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Oct;33(10):970-4
pubmed: 19001743
J Am Diet Assoc. 2008 Dec;108(12):2031-40
pubmed: 19027406
Annu Rev Nutr. 2009;29:223-56
pubmed: 19400751
Eur J Clin Nutr. 2009 Oct;63(10):1192-9
pubmed: 19603055
Appl Physiol Nutr Metab. 2009 Aug;34(4):595-602
pubmed: 19767793
Am J Clin Nutr. 2010 Mar;91(3):535-46
pubmed: 20071648
Intern Med. 2010;49(2):117-24
pubmed: 20075574
Proc Nutr Soc. 2010 Nov;69(4):518-27
pubmed: 20569523
Br J Nutr. 2010 Nov;104(10):1450-9
pubmed: 20594392
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
Diabetes Care. 2011 Jan;34(1):216-9
pubmed: 20889854
Am J Clin Nutr. 2011 Mar;93(3):494-9
pubmed: 21209225
Diabetes Metab Syndr Obes. 2010 Nov 02;3:373-85
pubmed: 21437107
Lipids Health Dis. 2011 Jul 06;10:1-6
pubmed: 21733182
Int J Pediatr Obes. 2011 Oct;6(5-6):361-88
pubmed: 21851163
Metab Syndr Relat Disord. 2012 Jun;10(3):181-8
pubmed: 22283632
Nutr Res. 2012 Feb;32(2):100-6
pubmed: 22348458
Nutr Hosp. 2011 Jul-Aug;26(4):685-91
pubmed: 22470011
J Nutr Health Aging. 2012;16(6):539-43
pubmed: 22659993
BMC Public Health. 2012 Jun 08;12:419
pubmed: 22682157
ISRN Endocrinol. 2012;2012:970629
pubmed: 22888450
BMC Public Health. 2014 Jun 30;14:666
pubmed: 24975509
Int J Public Health. 2015 Jul;60(5):561-72
pubmed: 25943424
PLoS One. 2015 Nov 30;10(11):e0143786
pubmed: 26618358
Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):27-35
pubmed: 26643208
Diabetes Metab Syndr. 2016 Jul-Sep;10(3):132-6
pubmed: 26810158
Clin Chim Acta. 2016 Apr 1;455:201
pubmed: 26908084
Arch Gerontol Geriatr. 2016 May-Jun;64:51-8
pubmed: 26952377
Metabolism. 2016 Apr;65(4):432-40
pubmed: 26975535
Springerplus. 2016 Mar 03;5:269
pubmed: 27006878
J Clin Diagn Res. 2016 Feb;10(2):OC27-31
pubmed: 27042498
Iran J Kidney Dis. 2016 May;10(3):126-34
pubmed: 27225720
Nutr Res Pract. 2016 Aug;10(4):411-7
pubmed: 27478548
Eur J Clin Invest. 2016 Oct;46(10):840-52
pubmed: 27529331
Eur J Clin Nutr. 2016 Dec;70(12):1454-1457
pubmed: 27677365
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S65-S71
pubmed: 28089168